Citation

William T. Shearer, Howard Max Rosenblatt, Stephen A. Spector, E. Richard Stiehm, E. Richard Stiehm, Diane W. Wara, Steven D. Douglas, Katherine Luzuriaga, Elizabeth (Betsy) J. McFarland, Ram Yogev, Mobeen H. Rathore, Wende Levy, Bobbie L. Graham, Rebecca Oyomopito, Rebecca S. Gelman. Normal Distribution of Peripheral Blood Mononuclear Cell (PBMC) Subsets from Birth to 18 years: The NIH NIAID DAIDS Pediatric AIDS Clinical Trials group P-1009 Protocol.. Journal of Allergy and Clinical Immunology. 2003. s271.

Citation

Leslie Carstensen Floren, Andrew A. Wiznia, Sandra Hayashi, Anura L. Jayewardene, Kenneth Stanley, George M. Johnson, Sharon Appelbaum Nachman, Paul Krogstad, Francesca Aweeka. Nelfinavir Pharmacokinetics in Stable Human Immunodeficiency Virus-Positive Children: Pediatric AIDS Clinical Trials Group Protocol 377. Pediatrics. 2003. 112: e220-e227.

Citation

Robert M. Grant, Daniel R. Kuritzkes, Victoria A. Johnson, John W. Mellors, John L. Sullivan, Ronald Swanstrom, Richard T. D'Aquila, Mark Van Gorder, Mark Holodniy, Robert M. Lloyd, Caroline Reid, Gillian F. Morgan, Dean L. Winslow. Accuracy of the TRUGENE HIV-1 genotyping kit. Journal of Clinical Microbiology. 2003. 41: 1586-93.

Citation

John Delehanty, Miklos P. Salgo, Jay Lalezari, W. Keith Henry, Mary O'Hearn, Julio S.G. Montaner, Peter J. Piliero, Benoit Trottier, Sharon Lynn Walmsley, Calvin J. Cohen, Daniel R. Kuritzkes, Joseph J. Eron, Jain Chung, Ralph A. DeMasi, Lucille Donatacci, Claude Drobnes. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. New England Journal of Medicine. 2003. 384: 2175-85.

Citation

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, Tarquin Collis, Aldo J. Lucchetti, Jorge L. Sanchez, James P. Hughes, Robert W. Coombs. Factors associated with oropharyngeal human immunodeficiency virus shedding. Journal of Infectious Diseases. 2003. 188: 142-5.

Citation

Philip M. Polgreen, Jinhua Xiang, Qing Chang, Jack T. Stapleton. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes and Infection. 2003. 5: 1255-61.

Citation

Sharon Lynn Walmsley, W. Keith Henry, Christine Katlama, Mark Nelson, Antonella Castagna, Jacques Reynes, Bonaventura Clotet, James Hui, Miklos P. Salgo, Ralph A. DeMasi, John Delehanty. Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide. Journal of Infectious Diseases. 2003. 188: 1827-33.

Citation

Mark Mirochnick, Alejandro Dorenbaum, Suzette Blanchard, Coleen Cunningham, Richard D. Gelber, Lynne M. Mofenson, Mary Culnane, John L. Sullivan. Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.. Journal of Acquired Immune Deficiency Syndromes. 2003. 33: 153-6.

Citation

Stuart E. Starr, Elizabeth J. McFarland, Petronella Muresan, Terence Fenton, Jane Pitt, Steven Douglas, Audra Deveikis, Myron Levin, Mobeen H. Rathore. Phase I/II Trial of Intravenous Recombinant Interleukin-2 in Human Immunodeficiency Virus-infected Children. AIDS. 2003. 17: 2181-2189.